National Salmonella Reference Laboratory, Division of Foodborne, Waterborne, and Environmental Diseases, MS-C03, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30333, USA.
J Clin Microbiol. 2011 Feb;49(2):565-73. doi: 10.1128/JCM.01323-10. Epub 2010 Dec 15.
Serotyping of Salmonella has been an invaluable subtyping method for epidemiologic studies for more than 70 years. The technical difficulties of serotyping, primarily in antiserum production and quality control, can be overcome with modern molecular methods. We developed a DNA-based assay targeting the genes encoding the flagellar antigens (fliC and fljB) of the Kauffmann-White serotyping scheme. Fifteen H antigens (H:a, -b, -c, -d, -d/j, -e,h, -i, -k, -r, -y, -z, -z(10), -z(29), -z(35), and -z(6)), 5 complex major antigens (H:G, -EN, -Z4, -1, and -L) and 16 complex secondary antigens (H:2, -5, -6, -7, -f, -m/g,m, -m/m,t, -p, -s, -t/m,t, -v, -x, -z(15), -z(24), -z(28), and -z(51)) were targeted in the assay. DNA probes targeting these antigens were designed and evaluated on 500 isolates tested in parallel with traditional serotyping methods. The assay correctly identified 461 (92.2%) isolates based on the 36 antigens detected in the assay. Among the isolates considered correctly identified, 47 (9.4%) were partially serotyped because probes corresponding to some antigens in the strains were not in the assay, and 13 (2.6%) were monophasic or nonmotile strains that possessed flagellar antigen genes that were not expressed but were detected in the assay. The 39 (7.8%) strains that were not correctly identified possessed an antigen that should have been detected by the assay but was not. Apparent false-negative results may be attributed to allelic divergence. The molecular assay provided results that paralleled traditional methods with a much greater throughput, while maintaining the integrity of the Kauffmann-White serotyping scheme, thus providing backwards-compatible epidemiologic data. This assay should greatly enhance the ability of clinical and public health laboratories to serotype Salmonella.
血清分型沙门氏菌已经是一种非常有价值的亚型方法为超过 70 年的流行病学研究。血清分型的技术困难,主要是在抗血清生产和质量控制,可以克服现代分子方法。我们开发了一个基于 DNA 的检测针对鞭毛抗原( fliC 和 fljB )的基因编码的科夫曼-怀特血清分型方案。15 H 抗原(H:A,-B,-C,-D,-D/J,-E,H,-I,-K,-R,-Y,-Z,-Z(10),-Z(29),-Z(35)和-Z(6)),5 个复杂的主要抗原(H:G,-EN,-Z4,-1 和-L)和 16 个复杂的次要抗原(H:2,-5,-6,-7,-F,-M/G,M,-M/M,T,-P,-S,-T/M,T,-V,-X,-Z(15),-Z(24),-Z(28)和-Z(51))在检测中针对。针对这些抗原的 DNA 探针的设计和评估在 500 株平行测试与传统的血清分型方法。检测正确鉴定 461 (92.2%)基于检测中检测到的 36 个抗原的分离株。在被认为是正确鉴定的分离株中,有 47 (9.4%)是部分血清型,因为与菌株中一些抗原相对应的探针不在检测中,而 13 (2.6%)是单相或非运动菌株,其具有鞭毛抗原基因不表达但在检测中检测到。39 (7.8%)未被正确鉴定的菌株具有本应通过检测检测到的抗原,但未检测到。明显的假阴性结果可能归因于等位基因的差异。分子检测提供的结果与传统方法平行,具有更大的吞吐量,同时保持科夫曼-怀特血清分型方案的完整性,从而提供向后兼容的流行病学数据。该检测法应大大增强临床和公共卫生实验室对沙门氏菌的血清分型能力。